Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1123 | 1089 | 1138 | 1423 | 1582 | 2430 |
Fund Return | 12.29% | 8.88% | 13.82% | 12.48% | 9.6% | 9.29% |
Place in category | 1005 | 1321 | 1123 | 640 | 632 | 360 |
% in Category | 47 | 62 | 55 | 37 | 40 | 36 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LansfOrsakringar Global Indexnara | 97.12B | 13.92 | 15.16 | 14.60 | ||
Lansforsakringar USA Indexnara | 38.59B | 15.30 | 17.74 | 17.88 | ||
Lansforsakringar Sverige Indexnara | 35.76B | 7.60 | 4.79 | 9.64 | ||
Lansforsakringar Global Hallbar A | 23.52B | 18.14 | 14.29 | 12.61 | ||
Lansforsakringar Global Hallbar B | 23.52B | 18.26 | 14.62 | 12.85 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Europafond Index | 18.73B | 12.82 | 12.43 | 9.45 | ||
Handelsbanken European Index utd | 18.73B | 12.82 | 12.43 | 8.97 | ||
SPP Aktiefond Europa | 17.15B | 12.19 | 12.76 | 9.46 | ||
Swedbank Robur Access Europa | 15.22B | 15.69 | 15.26 | 9.92 | ||
FI4000048988 | 10.78B | 11.71 | 11.06 | 9.95 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.96 | 903.3 | -1.05% | |
ASML Holding | NL0010273215 | 5.09 | 853.00 | -0.71% | |
AstraZeneca | GB0009895292 | 3.51 | 12,110.0 | -0.46% | |
Louis Vuitton | FR0000121014 | 3.19 | 783.20 | -0.36% | |
Nestle | CH0038863350 | 3.14 | 96.62 | +1.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review